79 related articles for article (PubMed ID: 22702530)
1. Comparison of antibiotic susceptibility of old and current Serratia.
Fusté E; Galisteo GJ; Jover L; Vinuesa T; Villa TG; Viñas M
Future Microbiol; 2012 Jun; 7(6):781-6. PubMed ID: 22702530
[TBL] [Abstract][Full Text] [Related]
2. Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan.
Wu LT; Tsou MF; Wu HJ; Chen HE; Chuang YC; Yu WL
Diagn Microbiol Infect Dis; 2004 Jun; 49(2):125-9. PubMed ID: 15183862
[TBL] [Abstract][Full Text] [Related]
3. Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii.
Stock I; Grueger T; Wiedemann B
Int J Antimicrob Agents; 2003 Jul; 22(1):35-47. PubMed ID: 12842326
[TBL] [Abstract][Full Text] [Related]
4. Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Serratia marcescens in China.
Yang HF; Cheng J; Hu LF; Ye Y; Li JB
J Antibiot (Tokyo); 2012 Oct; 65(10):531-3. PubMed ID: 22854338
[No Abstract] [Full Text] [Related]
5. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
Traub WH
Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of the SdeAB multidrug efflux pump in antibiotic-resistant clinical isolates of Serratia marcescens.
Dalvi SD; Worobec EA
Indian J Med Microbiol; 2012; 30(3):302-7. PubMed ID: 22885196
[TBL] [Abstract][Full Text] [Related]
8. Determination of the antibiotic resistance rates of
Simsek M
Niger J Clin Pract; 2019 Jan; 22(1):125-130. PubMed ID: 30666031
[TBL] [Abstract][Full Text] [Related]
9. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
[TBL] [Abstract][Full Text] [Related]
10. Natural antimicrobial susceptibilities of strains of 'unusual' Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea.
Stock I; Burak S; Sherwood KJ; Gruger T; Wiedemann B
J Antimicrob Chemother; 2003 Apr; 51(4):865-85. PubMed ID: 12654765
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
[TBL] [Abstract][Full Text] [Related]
12. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
[TBL] [Abstract][Full Text] [Related]
13. Comparison of integron-linked antibiotic resistance genes in strains of Salmonella spp. isolated from swine in Chile in 2005 and 2008.
Lapierre L; San Martín B; Araya-Jordán C; Borie C
Can J Microbiol; 2010 Jun; 56(6):515-21. PubMed ID: 20657622
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
Schmid B; Kayser FH
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
[TBL] [Abstract][Full Text] [Related]
15. Characterization of class 1 integrons and antimicrobial resistance in CTX-M-3-producing Serratia marcescens isolates from southern Taiwan.
Peng CF; Lee MF; Fu HT; Chen YJ; Hsu HJ
Jpn J Infect Dis; 2007 Sep; 60(5):250-6. PubMed ID: 17881862
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R
J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248
[TBL] [Abstract][Full Text] [Related]
17. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective.
Yoon HJ; Choi JY; Park YS; Kim CO; Kim JM; Yong DE; Lee KW; Song YG
Am J Infect Control; 2005 Dec; 33(10):595-601. PubMed ID: 16330308
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
[TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of antibiotic resistance in enteropathogenic Escherichia coli carrying extended-spectrum beta-lactamases recovered from diarrhoeic rabbits.
Poeta P; Radhouani H; Gonçalves A; Figueiredo N; Carvalho C; Rodrigues J; Igrejas G
Zoonoses Public Health; 2010 May; 57(3):162-70. PubMed ID: 19309480
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and resistance mechanisms involved in reduced susceptibility to amoxicillin/clavulanic acid in Klebsiella pneumoniae isolates from a chronic care centre.
Pérez-Moreno MO; Centelles-Serrano MJ; Cortell-Ortolá M; Fort-Gallifa I; Ruiz J; Llovet-Lombarte MI; Picó-Plana E; Jardí-Baiges AM
Int J Antimicrob Agents; 2011 May; 37(5):462-6. PubMed ID: 21316198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
